Turning Point Brands
TPB
57.37
-0.90
-1.54%
Turning Point Brands
US · TPB
#3152 by market cap
Listed 2016
57.37
-0.90
-1.54%
Live - 5344 symbols - heartbeat 28s ago
· 2026-10-08 08:05
Pre-market
57.45
+0.14%
After-hours
57.37
0.00%
- Market cap
- 1.15B
- P/E (TTM)i
- 24.94
- P/Bi
- 2.67
- EPSi
- 3.11
- Div yieldi
- 0.54%
- 52W posi
- 3%
Reader sentiment
Are you bullish or bearish on TPB?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 3.68, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +28.39% YoY
Margins
- Gross margin
- 57.08%
- Operating margin
- 20.59%
- Net margin
- 12.56%
Key ratios & quality
- Enterprise valuei
- 1.23B
- PEG ratioi
- 0.35
- Altman Z-Scorei
- 3.68
PEG uses trailing P/E against the 3-year net income growth rate (70.96%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 332.68M | 361.99M | 405.11M | 445.47M | 321.23M | 325.06M | 360.66M | 463.06M |
| Gross profit | 142.56M | 137.12M | 189.99M | 217.83M | 177.83M | 182.94M | 201.57M | 264.31M |
| Selling & admin expenses | 94.08M | 109.89M | 125.56M | 127.51M | 103.82M | 104.33M | 122.41M | 168.99M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 48.48M | 27.23M | 64.43M | 90.32M | 74.01M | 82.96M | 80.83M | 95.33M |
| Pretax profit | 31.57M | 19.10M | 50.15M | 65.30M | 42.07M | 62.07M | 64.96M | 83.14M |
| Tax | 6.29M | 2.86M | 11.96M | 14.04M | 10.98M | 24.00M | 16.93M | 14.99M |
| Net profit | 25.29M | 16.23M | 38.19M | 51.26M | 11.16M | 37.78M | 40.51M | 68.15M |
| Basic EPS | 1 | 1 | 2 | 3 | 1 | 2 | 2 | 3 |
| Diluted EPS | 1.28 | 0.78 | 1.85 | 2.52 | 0.64 | 2.01 | 2.14 | 3.11 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 106.44M | 116.63M | 118.98M | 121.01M | 124.28M | 142.96M |
| Gross profit | 59.61M | 66.62M | 70.43M | 67.65M | 68.30M | 93.70M |
| Selling & admin expenses | 36.42M | 40.30M | 44.54M | 47.73M | 55.81M | 76.99M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 23.19M | 26.33M | 25.89M | 19.93M | 12.48M | 16.71M |
| Pretax profit | 17.83M | 21.20M | 30.23M | 13.88M | 11.13M | 13.98M |
| Tax | 2.04M | 4.24M | 6.47M | 2.24M | -2.81M | 3.68M |
| Net profit | 15.79M | 16.96M | 23.76M | 11.64M | 13.94M | 10.30M |
| Basic EPS | 1 | 1 | 1 | 0 | 1 | 0 |
| Diluted EPS | 0.79 | 0.79 | 1.13 | 0.42 | 0.60 | 0.18 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 111.85M | 189.25M | 163.40M | 249.17M | 257.65M | 267.63M | 198.21M | 417.15M |
| Cash & ST investments | 3.31M | 95.25M | 41.77M | 128.32M | 106.40M | 116.73M | 46.16M | 222.76M |
| Inventory | 91.24M | 70.98M | 85.86M | 87.61M | 119.92M | 91.70M | 96.25M | 107.99M |
| Total assets | 339.38M | 446.58M | 496.05M | 601.56M | 572.11M | 569.37M | 493.35M | 763.75M |
| Total current liabilities | 63.77M | 55.89M | 56.63M | 40.34M | 41.38M | 100.35M | 44.82M | 75.01M |
| Short-term debt | 34.00M | 17.46M | 15.23M | 2.98M | 3.10M | 60.90M | 3.12M | 4.64M |
| Long-term debt | 186.72M | 268.95M | 302.11M | 414.17M | 406.76M | 307.06M | 248.60M | 293.63M |
| Total liabilities | 256,754,000.00 | 339,999,000.00 | 378,562,000.00 | 467,844,000.00 | 458,726,000.00 | 417,363,000.00 | 302,973,000.00 | 391,767,000.00 |
| Total equity | 82.62M | 106.59M | 117.49M | 133.72M | 113.38M | 152.01M | 190.38M | 371.98M |
| Retained earnings | -25.50M | -15.31M | 23.65M | 71.46M | 78.69M | 112.44M | 147.16M | 199.66M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 259.01M | 285.22M | 396.44M | 417.15M | 418.20M | 500.13M |
| Cash & ST investments | 99.64M | 109.93M | 201.19M | 222.76M | 192.44M | 268.31M |
| Inventory | 104.44M | 105.01M | 112.79M | 107.99M | 129.58M | 133.43M |
| Total assets | 564.55M | 595.79M | 742.85M | 763.75M | 772.10M | 855.20M |
| Total current liabilities | 58.60M | 67.51M | 71.34M | 75.01M | 71.28M | 88.22M |
| Short-term debt | 3.24M | 3.20M | 3.97M | 4.64M | 5.18M | 5.56M |
| Long-term debt | 293.06M | 293.14M | 293.36M | 293.63M | 293.89M | 294.15M |
| Total liabilities | 361,115,000.00 | 370,965,000.00 | 384,695,000.00 | 391,767,000.00 | 386,608,000.00 | 401,172,000.00 |
| Total equity | 203.44M | 224.82M | 358.15M | 371.98M | 385.49M | 454.02M |
| Retained earnings | 160.18M | 173.28M | 192.90M | 199.66M | 209.73M | 211.70M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 13.09M | 37.80M | 43.68M | 68.22M | 30.27M | 66.88M | 67.06M | 57.37M |
| Depreciation & amortization | 3.11M | 4.09M | 5.02M | 5.01M | 3.38M | 4.12M | 5.66M | 7.42M |
| Free cash flow | 10.82M | 32.98M | 37.54M | 62.06M | 22.44M | 61.17M | 62.44M | 43.85M |
| Dividends paid | -2.32M | -3.53M | -3.80M | -4.10M | -4.25M | -4.50M | -4.91M | -5.52M |
| Stock buybacks / issuance | 0 | 0 | -10.19M | -38.68M | -29.22M | 0 | -6.26M | 94.87M |
| Ending cash balance | 5.66M | 127.32M | 76.84M | 143.48M | 111.33M | 122.82M | 50.90M | 224.67M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 17.41M | 11.82M | 3.29M | 24.86M | -22.26M | 26.33M |
| Depreciation & amortization | 1.62M | 1.89M | 1.90M | 2.01M | 2.06M | 2.38M |
| Free cash flow | 15.22M | 7.83M | -721.00K | 21.51M | -27.40M | 26.24M |
| Dividends paid | -1.39M | -1.35M | -1.36M | -1.43M | -1.67M | -1.60M |
| Stock buybacks / issuance | -- | -- | 94.87M | -1.00K | -- | -- |
| Ending cash balance | 101.55M | 111.84M | 203.10M | 224.67M | 194.35M | 270.20M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 37.20 | 14.56 | 28.32 | 40.33 | 9.58 | 29.29 | 23.49 | 21.45 |
| ROA %i | 8.14 | 3.51 | 7.06 | 9.54 | 1.98 | 6.74 | 7.49 | 9.25 |
| ROIC %i | 13.30 | 8.16 | 11.56 | 13.66 | 4.62 | 8.94 | 10.25 | 13.03 |
| 5-year avg ROE %i | -- | -- | -- | 35.57 | 28.24 | 26.65 | 27.92 | 25.27 |
| EBIT margin %i | 14.03 | 9.16 | 15.62 | 19.26 | 8.56 | 18.83 | 21.89 | 23.44 |
| FCF / sales %i | 3.25 | 9.11 | 9.27 | 13.93 | 5.44 | 15.09 | 17.31 | 9.47 |
| Current ratioi | 1.75 | 3.39 | 2.89 | 6.18 | 6.23 | 2.67 | 4.42 | 5.56 |
| Quick ratioi | 0.09 | 1.83 | 0.90 | 3.34 | 2.77 | 1.45 | 1.58 | 3.52 |
| Debt / assetsi | 65.04 | 66.61 | 67.22 | 71.56 | 73.49 | 66.37 | 52.96 | 40.45 |
| LT debt / equityi | 225.98 | 262.72 | 280.53 | 325.34 | 373.82 | 209.94 | 137.33 | 85.90 |
| Interest coveragei | 3.09 | 1.91 | 3.13 | 4.19 | 1.82 | 5.21 | 5.65 | 4.28 |
| Revenue CAGR (3Y) %i | 19.03 | 20.63 | 12.34 | 10.22 | -3.90 | -7.08 | -6.80 | 12.96 |
| Net income CAGR (3Y) %i | 40.34 | -15.51 | 23.64 | 27.21 | -10.49 | 0.24 | -8.55 | 70.96 |
| FCF CAGR (3Y) %i | -22.02 | 77.26 | 10.71 | 78.99 | -12.05 | 17.67 | 0.20 | 25.02 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 23.46 | 22.31 | 19.78 | 21.45 | 19.61 | 13.74 |
| ROA %i | 7.33 | 7.36 | 8.51 | 9.25 | 8.29 | 6.14 |
| ROIC %i | 10.23 | 10.63 | 12.17 | 13.03 | 11.96 | 10.39 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 21.17 | 21.53 | 23.36 | 23.44 | 21.48 | 18.48 |
| FCF / sales %i | 14.42 | 12.83 | 8.94 | 9.47 | 0.25 | 3.87 |
| Current ratioi | 4.42 | 4.22 | 5.56 | 5.56 | 5.87 | 5.67 |
| Quick ratioi | 2.21 | 2.30 | 3.42 | 3.52 | 3.30 | 3.47 |
| Debt / assetsi | 54.00 | 51.14 | 41.35 | 40.45 | 40.16 | 36.33 |
| LT debt / equityi | 151.05 | 137.93 | 88.15 | 85.90 | 83.37 | 70.94 |
| Interest coveragei | 5.64 | 5.15 | 5.64 | 4.28 | 3.85 | 3.82 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Stoker’s products is the largest reported line at 75.25% of revenue, across 2 reported segments.
- The next-largest line, Zig-Zag products, is a distant second at 24.75% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Stoker’s products75.25%
Zig-Zag products24.75%
Quote time 2026-10-08 08:05:19 · For reference only, not investment advice and not tailored to your situation.